Home › Funds › Citadel Advisors › HUM

Citadel Advisors position in HUM

HUMANA INC · Health Care

Citadel Advisors reported holding 1,067,900 shares of HUM (HUMANA INC) in its Q3 2026 13F filing — a position valued at US$407.5M, representing 0.48% of its reported portfolio and ranking #37 among its reported holdings. Citadel Advisors has disclosed HUM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)1.07M sh
Reported value held$407.48M
Portfolio Weight0.48%
First reportedQ3 2021
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Citadel Advisors's HUM position evolved

Citadel Advisors first disclosed a stake in HUM in Q3 2021 at 1,026,881 shares (US$399.6M). The position peaked in Q1 2023 at 1,842,599 shares, worth US$894.5M. Across 21 filings, Citadel Advisors increased the stake 10 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,067,900 shares valued at US$407.5M — an increase of 618,878 shares quarter over quarter.. Notable position changes include a 320% increase in Q1 2026 (shares rose 130% over the following quarter), a 217% increase in Q2 2026 (shares fell 4% over the following quarter), a 138% increase in Q3 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 1.03M $399.61M New
Q4 2021 971.12K $450.46M Reduce
Q1 2022 1.39M $604.34M Add
Q2 2022 1.55M $725.49M Add
Q3 2022 1.81M $880.32M Add
Q4 2022 1.10M $565.22M Reduce
Q1 2023 1.84M $894.51M Add
Q2 2023 1.00M $447.80M Reduce
Q3 2023 378.00K $183.90M Reduce
Q4 2023 599.60K $274.50M Add
Q1 2024 912.20K $316.28M Add
Q2 2024 716.50K $267.72M Reduce
Q3 2024 517.39K $163.88M Reduce
Q4 2024 1.03M $261.25M Add
Q1 2025 703.90K $186.25M Reduce
Q2 2025 703.12K $171.90M Hold
Q3 2025 322.02K $83.78M Reduce
Q4 2025 33.75K $8.64M Reduce
Q1 2026 141.65K $24.56M Add
Q2 2026 449.02K $178.36M Add
Q3 2026 1.07M $407.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HUM and 13F data

HUM (HUMANA INC) is a Health Care company. 32 other funds we track also report a position in HUM — the largest reported positions include Dodge & Cox (US$4.35B), DODGE & COX (US$3.90B), Sessa Capital IM, L.P. (US$1.42B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HUM

All HUM fund holders →

FAQ

How long has Citadel Advisors held HUM?

Citadel Advisors has disclosed HUM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Citadel Advisors's current position in HUM?

As of Q3 2026, Citadel Advisors holds 1.07M shares of HUM (HUMANA INC), valued at $407.48M, representing 0.48% of its reported portfolio and ranking #37.

Has Citadel Advisors been buying or selling HUM?

In the latest 13F filing (Q3 2026), Citadel Advisors increased its position in HUM. The position peaked in Q1 2023 at 1.84M shares.

Which other funds hold HUM?

Other major institutional holders of HUM include Dodge & Cox, DODGE & COX, Sessa Capital IM, L.P., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.